Bluejay Diagnostics (BJDX) Cash & Equivalents Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.15% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 24.05% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -7.50% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 100.41% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -22.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 20.15% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 23.57% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -7.71% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 156.03% |
| 10 | Bluejay Diagnostics | 572,394.44 | -3.11 Mn | - | 18.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.24% |
| Dec 31, 2025 | 20.06% |
| Sep 30, 2025 | -46.45% |
| Jun 30, 2025 | -44.86% |
| Mar 31, 2025 | 17.10% |
| Dec 31, 2024 | 94.79% |
| Sep 30, 2024 | 13.37% |
| Jun 30, 2024 | 58.00% |
| Mar 31, 2024 | -60.76% |
| Dec 31, 2023 | -78.17% |
| Sep 30, 2023 | -61.80% |
| Jun 30, 2023 | -66.75% |
| Mar 31, 2023 | -60.40% |
| Dec 31, 2022 | -46.90% |
| Sep 30, 2022 | 470.33% |
| Dec 31, 2021 | 1,987.75% |
| Sep 30, 2021 | 3,102.15% |